|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:bfsLayer
|
6
|
|
gptkbp:bfsParent
|
gptkb:Tagamet
|
|
gptkbp:brand
|
gptkb:Tagamet
|
|
gptkbp:class
|
H2 receptor antagonist
|
|
gptkbp:clinical_trial
|
Phase IV
|
|
gptkbp:code
|
A02 B A01
|
|
gptkbp:contraindication
|
liver disease
renal impairment
pregnancy category C
|
|
gptkbp:effective_date
|
gptkb:1977
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:formulation
|
gptkb:product
gptkb:tablet
injection
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Tagamet R
|
|
gptkbp:ingredients
|
C10 H13 N5 S
|
|
gptkbp:interacts_with
|
gptkb:phenytoin
gptkb:theophylline
gptkb:warfarin
benzodiazepines
|
|
gptkbp:is_available_on
|
over-the-counter
prescription
|
|
gptkbp:is_used_for
|
treating gastroesophageal reflux disease (GERD)
treating Zollinger-Ellison syndrome
treating ulcers
|
|
gptkbp:lifespan
|
2 hours
|
|
gptkbp:manager
|
oral
|
|
gptkbp:manufacturer
|
gptkb:Smith_Kline_Beecham
|
|
gptkbp:marketed_as
|
gptkb:government_agency
gptkb:Australia
gptkb:United_Kingdom
gptkb:United_States
gptkb:Native_American_tribe
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:previous_name
|
gptkb:Cimetidine
|
|
gptkbp:side_effect
|
dizziness
headache
muscle pain
nausea
confusion
seizures
diarrhea
rash
arrhythmias
thrombocytopenia
hypotension
visual disturbances
gynecomastia
elevated liver enzymes
leukopenia
impotence
|
|
gptkbp:treatment
|
gptkb:Zollinger-Ellison_syndrome
gptkb:GERD
peptic ulcers
|
|
gptkbp:type_of
|
51481-61-9
|
|
gptkbp:weight
|
252.31 g/mol
|